Transfer Factor Plus™: An In Vivo (in body) Study
April 27,
2000
Purpose of
Study: To determine the effectiveness of natural products in increasing
the function of Natural Killer (NK) Cell activity in chronic illnesses. In
this study persons suffering from Fibromyalgia were chosen to take part in
an in vivo study.
Background: It is felt that chronic illnesses represent immune system
failures in most instances, particularly in the Fibromyalgia Syndrome. There
have been many published reports of low Natural Killer Cell activity or
function in persons with Fibromyalgia.
Natural Killer Cells: Natural Killer Cells are the first line of
defense in our innate immune systems. Natural Killer Cells are lethal
lymphocytes containing granules filled with potent chemicals. They do not
need to recognize a particular threat but rather attack anything recognized
as "nonself". They protect against and target tumor cells and a wide variety
of infectious microbes, particularly virally infected cells. NK cells kill
by binding to their targets and delivering a lethal burst of chemicals that
produce holes in the target cells' membrane. Fluids seep in and leak out and
the cells burst and die.
Patient Selection: Nine patients were enrolled in the study who had
been diagnosed with Fibromyalgia and who weren't taking any known immune
stimulants at the time of enrollment.
| Nutritional Supplements Used in Study:* | |
| Name: | Dosage: |
| Transfer Factor Plus™ | One, twice daily, days 1 - 10 |
| - | Two, twice daily, days 11 - 20 |
| Fibro AMJ™ Daytime Formula | Two, three times daily |
| Fibro AMJ™ Nighttime Formula | One, nightly |
| Choice 50™ Antioxidants | One, twice daily |
Length of Study:
Blood work was drawn on day 1 before the beginning of the use of the
products and on day 21 after using the products for 20 consecutive days.
Comment: If a person has a Natural Killer Cell activity below 20%, they are felt to be more susceptible to acute or chronic illnesses, or to have a compromised ability to recover from existing illnesses. All of the nine volunteers had NK Cell function of less than 20% activity with a range of 6 to 13%, and an average of the group of 10% activity.
Summary: All of the nine patients had significant increases in Natural Killer Cell activity. The levels after 20 days on the products now ranged form 19.5% to 35.5% with an average of 26.9%. This represented an increase of 2.69 times the baseline average of 10%, or 269% of the baseline average.
Rob Robertson, M.D.
Paducah, KY
*Products provided by 4Life Research™
9850 South 350 West, Sandy,UT 84070
